ASX:ALT

Analytica Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume37,562 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive ALT News and Ratings via Email

Sign-up to receive the latest news and ratings for Analytica and its competitors with MarketBeat's FREE daily newsletter.


About Analytica

Analytica Limited designs, develops, and supplies medical devices in Australia, the United Kingdom, and the United States. The company's lead product is PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.88 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Analytica (ASX:ALT) Frequently Asked Questions

What stocks does MarketBeat like better than Analytica?

Wall Street analysts have given Analytica a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Analytica wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Analytica's key executives?

Analytica's management team includes the following people:
  • Dr. Michael Monsour, Exec. Chairman
  • Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE, Chief Exec. Officer
  • Mr. Ross Mangelsdorf B.Bus, FCA, CTA, FTIA, MAICD, CFO & Exec. Director
  • Ms. Chelsea Cornelius, Product Devel. & Operations Mang.
  • Ms. Megan Henken, VP of Global Marketing
  • Mr. Bryan Dulhunty C.A., BEc, ACA, Company Sec.

Who are some of Analytica's key competitors?

What is Analytica's stock symbol?

Analytica trades on the ASX under the ticker symbol "ALT."

How much money does Analytica make?

Analytica has a market capitalization of $0.00 and generates $801,435.00 in revenue each year.

How many employees does Analytica have?

Analytica employs 43 workers across the globe.

What is Analytica's official website?

The official website for Analytica is www.analyticamedical.com.

Where are Analytica's headquarters?

How can I contact Analytica?

Analytica's mailing address is 910 Clopper Rd Ste 201S, Gaithersburg, Maryland 20878-1361. The company can be reached via phone at 61 7 3278 1950.


This page was last updated on 9/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.